{"result": "(\"entity\"<|>TASK FORCE FOR THE REVISION OF SAFE PRACTICES FOR PARENTERAL NUTRITION<|>ORGANIZATION<|>A group focused on establishing safe practices for parenteral nutrition, contributing to guidelines and recommendations in the field of nutritional medicine.)\n##\n(\"entity\"<|>JPEN J PARENTER ENTERAL NUTR<|>ORGANIZATION<|>A journal that publishes research and guidelines related to parenteral and enteral nutrition.)\n##\n(\"entity\"<|>GERMAN SOCIETY FOR NUTRITIONAL MEDICINE<|>ORGANIZATION<|>A professional organization that provides guidelines and recommendations for nutritional practices in Germany.)\n##\n(\"entity\"<|>EUROPEAN SOCIETY FOR PARENTERAL AND ENTERAL NUTRITION<|>ORGANIZATION<|>A society that focuses on the advancement of parenteral and enteral nutrition practices across Europe.)\n##\n(\"entity\"<|>SOCIETY OF CRITICAL CARE MEDICINE<|>ORGANIZATION<|>An organization dedicated to improving care for critically ill patients, including guidelines for nutrition support therapy.)\n##\n(\"entity\"<|>AMERICAN SOCIETY FOR PARENTERAL AND ENTERAL NUTRITION<|>ORGANIZATION<|>A professional society that promotes the practice of parenteral and enteral nutrition in the United States.)\n##\n(\"entity\"<|>NUTRITION CLINICAL PRACTICE<|>ORGANIZATION<|>A journal that publishes articles on clinical nutrition practices and research.)\n##\n(\"entity\"<|>NUTRITION<|>EVENT<|>A field of study and practice focused on the dietary needs and nutritional support of individuals, particularly in clinical settings.)\n##\n(\"entity\"<|>PARENTERAL NUTRITION<|>EVENT<|>A medical method of providing nutrition to patients who cannot eat or absorb food through the gastrointestinal tract.)\n##\n(\"entity\"<|>GLUTAMINE<|>EVENT<|>An amino acid that is often discussed in the context of nutritional support, particularly in critical illness and surgical recovery.)\n##\n(\"entity\"<|>BRANCHED CHAIN AMINO ACIDS<|>EVENT<|>A group of amino acids that are important in nutrition, particularly in the context of parenteral nutrition for patients undergoing surgery.)\n##\n(\"entity\"<|>HOSPITALIZED ADULT PATIENTS<|>PERSON<|>Patients who are receiving care in a hospital setting, often requiring specialized nutritional support.)\n##\n(\"relationship\"<|>TASK FORCE FOR THE REVISION OF SAFE PRACTICES FOR PARENTERAL NUTRITION<|>JPEN J PARENTER ENTERAL NUTR<|>The Task Force contributes to the guidelines published in the JPEN J Parenter Enteral Nutr journal<|>8)\n##\n(\"relationship\"<|>GERMAN SOCIETY FOR NUTRITIONAL MEDICINE<|>EUROPEAN SOCIETY FOR PARENTERAL AND ENTERAL NUTRITION<|>Both organizations work towards improving nutritional practices and guidelines in their respective regions<|>6)\n##\n(\"relationship\"<|>SOCIETY OF CRITICAL CARE MEDICINE<|>AMERICAN SOCIETY FOR PARENTERAL AND ENTERAL NUTRITION<|>Both societies collaborate on guidelines for nutrition support therapy in critically ill patients<|>7)\n##\n(\"relationship\"<|>NUTRITION CLINICAL PRACTICE<|>JPEN J PARENTER ENTERAL NUTR<|>Both journals publish research and guidelines related to clinical nutrition practices<|>7)\n##\n(\"relationship\"<|>PARENTERAL NUTRITION<|>HOSPITALIZED ADULT PATIENTS<|>Parenteral nutrition is often administered to hospitalized adult patients who cannot consume food orally<|>9)\n##\n(\"relationship\"<|>GLUTAMINE<|>PARENTERAL NUTRITION<|>Glutamine is frequently discussed in the context of its role in parenteral nutrition for critically ill patients<|>8)\n##\n(\"relationship\"<|>BRANCHED CHAIN AMINO ACIDS<|>PARENTERAL NUTRITION<|>Branched chain amino acids are important components of parenteral nutrition formulations<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: D, Krum P, Petersen C, Sacks G et al. Task Force for the Revision of Safe Practices for Parenteral Nutrition. Safe practices for parenteral nutrition. JPEN J Parenter Enteral Nutr. 2004; 28(6): S39-S70.\n20. Miller SJ. Commercial premixed parenteral nutrition: is it right for your institution? Nutr Clin Pract. 2009; 24(4): 459-469.\n21. Rollins CJ. Total nutrient admixtures: stability issues and their impact on nursing practice. J Intraven Nurs. 1997; 20(6): 299-304.\n22. Erdman SH, McElwee CL, Kramer JM, Zuppan CW, White JJ, Grill BB. Central line occlusion with\n---\n776      BLOQUE: SOPORTE NUTRICIONAL AVANZADO\n\nthree-in-one nutrition admixtures administered at home. JPEN J Parenter Enteral Nutr. 1994; 18(2): 177-181.\n\n23. Hardy G, Puzovic M. Formulation, stability, and administration of parenteral nutrition with new lipid emulsions. Nutr Clin Pract. 2009; 24(5): 616-625.\n\n24. Yarandi SS, Zhao VM, Hebbar G, Ziegler TR. Amino acid composition in parenteral nutrition: what is the evidence? Curr Opin Clin Nutr Metab Care. 2011 Jan; 14(1): 75-82.\n\n25. Mundi MS, Nystrom EM, Hurley DL, McMahon MM Management of Parenteral Nutrition in Hospitalized Adult Patients. JPEN J Parenter Enteral Nutr. 2016 Sep 1. [Epub ahead of print].\n\n26. Kreymann KG, Berger MM, Deutz NE, Hiesmayr M, Jolliet P, Kazandjiev G, Nitenberg G, van den Berghe G, Wernerman J, DGEM (German Society for Nutritional Medicine), ESPEN (European Society for Parenteral and Enteral Nutrition), et al. ESPEN Guidelines on Enteral Nutrition: Intensive care. Clin Nutr. 2006; 25: 210–23].\n\n27. McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and AmericanSociety for Parenteral and Enteral Nutrition (ASPEN). JPEN J Parenter Enteral Nutr. 2016; 40(2): 159-211.\n\n28. Plauth M, Cabré E, Campillo B, et al. ESPEN Guidelines on parenteral nutrition: hepatology. Clin Nutr. 2009; 28: 436–444.\n\n29. Sun LC, Shih YL, Lu CY, et al. Randomized, controlled study of branched chain amino acidenriched-total parenteral nutrition in malnourished patients with gastrointestinal cancer undergoing surgery. Am Surg. 2008; 74: 237–242.\n\n30. Kuhn KS, Muscaritoli M, Wischmeyer P, Stehle P. Glutamine as indispensable nutrient in oncology: experimental and clinical evidence. Eur J Nutr. 2010; 49: 197–210.\n\n31. When Is It Appropriate to Use Glutamine in Critical Illness? Nutr Clin Pract. 2016 Aug; 31(4): 445-50.\n\n32. Ziegler TR, May AK, Hebbar G, et al. Efficacy and safety of glutaminesupplemented parenteral nutrition in surgical ICU patients: an American multicenter randomized controlled trial. Ann Surg. 2016; 263(4): 646-655.\n\n33. Gianotti L, Braga M, Biffi R, et al. Perioperative intravenous glutamine supplemetation in majorabdominal surgery for cancer: a randomized multicenter trial. Ann Surg. 2009; 250: 684–690. 33.\n\n34. Yeh CN, Lee HL, Liu YY, et al. The role of parenteral glutamine supplement for surgical patient perioperatively: result of a single center, prospective and controlled study. Langenbecks Arch Surg. 2008; 393: 849–855.\n\n35. Luo M, Bazargan N, Griffith DP, et al. Metabolic effects of enteral versus parenteral alanylglutamine dipeptide administration in critically ill patients receiving enteral feeding: a pilot study.Clin Nutr. 2008; 27: 297–306.\n\n36. Tan HB, Danilla S, Murray A, et al. Immunonutrition as an adjuvant therapy for burns. Cochrane Database Syst Rev. December 2014.\n\n37. Tappy L. Carbohydrates. Home parenteral Nutrition. Cabi. pp. 207-15. London, 2006.\n\n38. Ferezou J, Bach AC. Structure and metabolic fate of triacylglycerol- and phospholipid-rich particles of commercial parentral fat emulsions.Nutrition.1999 Jan; 15(1): 44-50.\n\n39. Zugasti A., Petrina E., Elizondo J. Hepatopatía asociada a nutrición parenteral y emulsiones lipídicas Endocrinologia y Nutricion, 2015 (62): 285-289.\n\n40. Vanek VW, Seidner DL\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}